Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kruti Sheth Nair & Chaitra Ujjani. (2015) The expanding role of bendamustine in chronic lymphocytic leukemia. Blood and Lymphatic Cancer: Targets and Therapy 5, pages 65-74.
Read now
Read now
Chaitra Ujjani & Bruce D Cheson. (2014)
Bendamustine in the treatment of chronic lymphocytic leukemia. Expert Opinion on Orphan Drugs 2:6, pages 617-623.
Read now
Read now
Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, Kristina Kleboth, Jörg Thomalla, Christoph van Roye & Hubert Köppler. (2013) Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions. Leukemia & Lymphoma 54:8, pages 1640-1646.
Read now
Read now
Chaitra Ujjani & Bruce D Cheson. (2010) Bendamustine in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. Expert Review of Anticancer Therapy 10:9, pages 1353-1365.
Read now
Read now
Fredrick Hagemeister & George Manoukian. (2009) Bendamustine in the treatment of non-Hodgkin’s lymphomas. OncoTargets and Therapy 2, pages 269-279.
Read now
Read now
Ibrahim T Aldoss, Susan M Blumel & Philip J Bierman. (2009) The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma. Cancer Management and Research 1, pages 155-165.
Read now
Read now
Articles from other publishers (9)
Ranjit Singh, Anjleena Malhotra & Ranju Bansal. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
499
537
.
Rafael González‐Castro, Miguel A. Gómez‐Lim & Fabien Plisson. (2020) Cysteine‐Rich Peptides: Hyperstable Scaffolds for Protein Engineering. ChemBioChem 22:6, pages 961-973.
Crossref
Crossref
Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh. (2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget 7:30, pages 48692-48731.
Crossref
Crossref
Monika Gaba & Chander Mohan. (2015) Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions. Medicinal Chemistry Research 25:2, pages 173-210.
Crossref
Crossref
Alexander V. Aksenov, Alexander N. Smirnov, Nicolai A. Aksenov, Asiyat S. Bijieva, Inna V. Aksenova & Michael Rubin. (2015) Benzimidazoles and benzoxazoles via the nucleophilic addition of anilines to nitroalkanes. Organic & Biomolecular Chemistry 13:14, pages 4289-4295.
Crossref
Crossref
Aaron G. Poth, Lai Y. Chan & David J. Craik. (2013) Cyclotides as grafting frameworks for protein engineering and drug design applications. Peptide Science 100:5, pages 480-491.
Crossref
Crossref
Suzanne Lentzsch, Amy O'Sullivan, Ryan C. Kennedy, Mohammad Abbas, Lijun Dai, Silvana Lalo Pregja, Steve Burt, Michael Boyiadzis, G. David Roodman, Markus Y. Mapara, Mounzer Agha, John Waas, Yongli Shuai, Daniel Normolle & Jeffrey A. Zonder. (2012) Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study. Blood 119:20, pages 4608-4613.
Crossref
Crossref
Nishant Tageja. (2011) Bendamustine: Safety and Efficacy in the Management of Indolent Non-Hodgkins Lymphoma. Clinical Medicine Insights: Oncology 5, pages CMO.S6085.
Crossref
Crossref
Nishant Tageja & Jasdeepa Nagi. (2010) Bendamustine: something old, something new. Cancer Chemotherapy and Pharmacology 66:3, pages 413-423.
Crossref
Crossref